Oaklander welcomed the news of the approval of the new vaccine, saying that more adults should be vaccinated against shingles. In the United States alone, there are an estimated 1 million cases of shingles a year, and one in three people can expected to develop the condition during their lifetime.
6 brokerages have issued twelve-month price objectives for Arbutus Biopharma Corp's shares. Their forecasts range from $5.00 to $10.00. On average, they anticipate Arbutus Biopharma Corp's stock price to reach $7.00 in the next year.
While there is no information yet on the pricing for Basaglar, we speculate that it will be at least slightly cheaper than both Lantus and Novo Nordiskâs Levemir (insulin detemir), which at retail value cost $430.99 and $380.99, respectively, for a carton of five pens at a local Walgreenâs pharmacy.